Four Startups Advance to Spring 2023 George Shultz Innovation Fund Finals

Four startups innovating in the life sciences, energy, healthcare IT, and medical device spaces will each vie for up to $250,000 in co-investment as finalists in the Spring 2023 cohort…

2 Startups Awarded $175,000 Each to Further Develop Cancer Treatment Technologies

Alnair Therapeutics and Riptide Therapeutics have been awarded investments from the George Shultz Innovation Fund to further develop their cancer treatment technologies. Both will receive $175,000 investments from the Fund.…

Riptide Therapeutics Awarded $175,000 From George Shultz Innovation Fund

The George Shultz Innovation Fund (GSIF), managed by the Polsky Center for Entrepreneurship and Innovation, recently selected Riptide Therapeutics, a biopharmaceutical startup led by University of Chicago and Northwestern University…

Alnair Therapeutics Awarded $175,000 From George Shultz Innovation Fund

The George Shultz Innovation Fund (GSIF), managed by the Polsky Center for Entrepreneurship and Innovation, recently selected oncology startup Alnair Therapeutics as a Fall 2022 cohort award winner. The company,…

Digital Health, Therapeutics Startups Selected for George Shultz Innovation Fund Finals

The Polsky Center for Entrepreneurship and Innovation at the University of Chicago has announced the companies selected for the 2022 fall cohort of the George Shultz Innovation Fund. Managed by…

ClostraBio Closes $4 Million Series A to Transform Intestinal Health with Plug-and-Play Drug Delivery Platform

University of Chicago spinout ClostraBio has closed a $4 million Series A-1 financing round to accelerate development of its lead candidate, expand its plug-n-play platform, and build out its team.…

Fermilab Engineer Scales Quantum Startup with Support from UChicago

Lismikro – taking its name from the Greek for “micro” – is developing innovative low-power microchip controllers to solve the hardware bottleneck and unleash the full potential of quantum computers.…

Met With Too Many Late-Stage Diagnoses, Doctors Create Novel Test to Earlier Detect Cancer in Your Saliva

OrisDX has developed a novel saliva-based molecular test to detect and diagnose oral cancer earlier – improving patient outcomes and saving lives. The Chicago-based startup was formed based on a…

3 Startups Awarded $200,000 Each to Build Out Teams, Launch Novel Products

Flow Medical, Lismikro, and OrisDX each have been awarded a $200,000 co-investment from the George Shultz Innovation Fund to further develop their technologies. Managed by the Polsky Center for Entrepreneurship…

Cancer Detection, Oil Spill Cleanup, Quantum Computing, and a New Medical Device: Meet the Spring 2022 Innovation Fund Finalists

Four teams have been selected as finalists for the George Shultz Innovation Fund spring 2022 investment cycle – bringing to the forefront solutions for scaling quantum computers, sustainably cleaning oil…

UChicago Spinout Super.tech Acquired by Quantum Ecosystem Leader ColdQuanta

A University of Chicago quantum software spinout and Duality Cohort 1 participant, Super.tech has been acquired by a global quantum ecosystem leader, ColdQuanta. Super.tech is embedded in Argonne National Laboratory's…

UChicago Doctors Wanted a Better Medical Device to Treat Pulmonary Embolism. Here Is How They Made Their Own

FLOW Medical is developing a multi-function catheter to help diagnose and treat venous thromboembolic disease while maximizing functionality, optimizing safety, and minimizing complexity. Founders Jonathan Paul, associate professor of medicine,…